What the Israel-Iran Conflict Means for Oil Output and Prices
Rebecca Babin, CIBC Private Wealth Group senior energy trader, discusses what the Israel-Iran conflict could means for oil markets on "Bloomberg The Close." (Source: Bloomberg)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Lifeward Announces Pricing of $2.6 Million Public Offering
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) ('Lifeward' or the 'Company'), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a public offering of an aggregate of 4,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company's ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant. The ordinary warrants will have an exercise price of $0.65 per ordinary share, will be exercisable immediately upon issuance and will expire on the five-year anniversary of the issuance date. The closing of the offering is expected to occur on or about June 26, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.6 million before deducting the placement agent's fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the ordinary warrants, if fully exercised on a cash basis, will be approximately $2.6 million. No assurance can be given that any of the ordinary warrants will be exercised. The Company intends to use the net proceeds from this offering for its continuing commercial efforts, working capital and general corporate purposes. The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-288172), as amended, which was declared effective by the Securities and Exchange Commission (the "SEC") on June 25, 2025. The offering is being made only by means of a prospectus forming part of the effective registration statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at and a final prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC's website at and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Lifeward Ltd. Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. Lifeward®, ReWalk®, ReStore®, and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates. Forward-Looking Statements In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include statements related to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds from the offering, the exercise of the ordinary warrants prior to their expiration and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward's control. Important factors that could cause the Company's actual results to differ materially from those indicated in the forward-looking statements, including risks and uncertainties related to market conditions, are more fully discussed in the Company's periodic filings with the SEC, including the risk factors described under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 7, 2025 and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company's actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise. Lifeward Media Relations: Kathleen O'DonnellVice President, Marketing & New Business DevelopmentLifeward Ltd.E: media@ Lifeward Investor Contact:Mike LawlessChief Financial OfficerLifeward Ltd.E: ir@
Yahoo
33 minutes ago
- Yahoo
UAE Wound Wash Market Size, Share & Trends Analysis Report and Competitive Analysis, 2025-2030
The UAE Wound Wash Market is projected to grow to USD 253.22 million by 2030, driven by a 7.20% CAGR. Factors include an aging population, rising surgical procedures, and chronic wounds prevalence. Increased healthcare facilities and road accidents also boost demand. UAE Wound Wash Market Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "UAE Wound Wash Market Size, Share & Trends Analysis Report by Product (Antiseptic, Saline Solution), Product, Product Form, Application, End-use with Growth Forecasts, Key Companies and Competitive Analysis, 2025-2030" has been added to UAE wound wash market, valued at USD 167.63 million in 2024, is projected to reach USD 253.22 million by 2030, growing at a CAGR of 7.20%. This trajectory is underpinned by an increase in surgical procedures and a growing aging population, necessitating more advanced wound care solutions like wound wash products. Chronic wounds, particularly diabetic foot and pressure ulcers, further drive demand. As per Khalifa University, by 2031, nearly 1.6 million UAE residents could be afflicted with Type 2 diabetes, potentially escalating diabetes-related healthcare costs to USD 3.4 billion. In the first quarter of 2023, Dubai licensed 143 new health facilities, boosting the total to 4,609, an 11.5% rise compared to the previous year. This expansion of clinics and specialty centers notably improves access to medical services, including wound care for chronic conditions. Each new facility represents a burgeoning consumer base for wound care products, such as wound wash solutions, essential for routine procedures like dressing changes, minor surgeries, and diabetic wound care. Specialized centers like diabetic care and podiatry clinics emphasize the use of advanced wound wash solutions, enhancing adoption rates across the healthcare sector. The aging population in the UAE is anticipated to augment the demand for wound care products due to the prevalence of conditions associated with aging, like ulcers and surgical wounds. Elderly individuals are increasingly vulnerable to complications such as diabetes and vascular diseases, heightening the need for specialized wound management. Healthcare providers are adapting to this demographic shift with greater focus on geriatric care, projecting an increase in demand for efficient wound care products that promote healing and prevent infections. The UAE's rising road accidents, with an 11% increase to 4,391 incidents in 2023, emphasize the need for efficient wound care solutions for trauma treatment. Wound washes are critical for cleaning and disinfecting injuries, aiding in infection prevention. As accidents proliferate, demand surges across hospitals, emergency teams, and rehabilitation centers, necessitating high-quality wound cleaning solutions for effective treatment and accelerated recovery. UAE Wound Wash Market Report Segmentation forecasts revenue growth and trend analyses from 2018 to 2030, covering product, product form, application, and end-use categories. Product Outlook (Revenue, USD Million, 2018-2030) Antiseptic Povidone Iodine Chlorhexidine Polyhexanide (PHMB) Others Saline Solution Irrigation Solution Pulsed Lavage Systems Disposable Reusable Semi Disposable Others Product Form Outlook (Revenue, USD Million, 2018-2030) Solutions Sprays Wipes Others Application Outlook (Revenue, USD Million, 2018-2030) Acute Wounds Surgical & Traumatic Wounds Burns & Lacerations Chronic Wounds Diabetic Foot Ulcers Pressure Ulcers Venous Leg Ulcers Other Chronic Wounds End Use Outlook (Revenue, USD Million, 2018-2030) Hospitals Specialty Clinics Ambulatory Surgery Centers Military & Defense Others This report addresses: Market intelligence for informed decision-making Market estimates from 2018 to 2030 Growth opportunities and trend analysis Segment and regional revenue forecasts Competition strategy and market share analysis Product innovation insights Why Should You Buy This Report? Comprehensive Market Analysis: Detailed insights across major regions and segments. Competitive Landscape: Explore market presence of key players. Future Trends: Discover trends and drivers shaping the market's future. Actionable Recommendations: Insights for uncovering new revenue streams and guiding strategic decisions. Key Attributes: Report Attribute Details No. of Pages 120 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $167.63 Million Forecasted Market Value (USD) by 2030 $253.22 Million Compound Annual Growth Rate 7.2% Regions Covered United Arab Emirates Companies Featured The major companies featured in this UAE Wound Wash market report include: Atlantis Consumer Healthcare Inc. Medline Industries, LP B. Braun SE Johnson & Johnson Consumer Inc. (Johnson & Johnson) Zimmer Biomet Urgo Medical North America (URGO Group) Coloplast Corp (Coloplast Group) Molnlycke Health Care AB Cardinal Health Armis Biopharma Bravida Medical Irrimax Corporation BD Sanara MedTech Inc. Pure&Clean Innovacyn, Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment UAE Wound Wash Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
33 minutes ago
- Bloomberg
Bloomberg Surveillance TV: June 25, 2025
- Matthew Hornbach, Global Head: Macro Strategy at Morgan Stanley - Amrita Sen, Founder and Director of Research at Energy Aspects - Jon Lieber, Head: Research at Eurasia Group - Sheila Kahyaoglu, Managing Director: Equity Research at Jeffries Matthew Hornbach, Global Head: Macro Strategy at Morgan Stanley, joins for a look at inflation and outlook for the US economy. Amrita Sen, Founder and Director of Research at Energy Aspects, talks about the possibility of an oil spike amid uncertainty surrounding the Israel-Iran conflict. Jon Lieber, Head: Research at Eurasia Group, talks about rising geopolitical risks. Sheila Kahyaoglu, Managing Director: Equity Research at Jeffries, joins to discuss the outlook for the airline industry amid defense spending changes.
